StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 09/05/2013 -- StockRunway.com issues special report on: Halozyme Therapeutics, Inc.(NASDAQ:HALO ),GTx, Inc.(NASDAQ:GTXI), Apollo Investment Corp.(NASDAQ:AINV), PMC-Sierra Inc(NASDAQ:PMCS)
Halozyme Therapeutics, Inc.(NASDAQ:HALO ) stock is at $8.69,up 1.64% from its previous close of $8.55. The stock opened the session at $8.55and touched its highest price point at $8.79. Halozyme Therapeutics, Inc stock’s lowest price point for the session stood at $8.43.Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive 34.31% during the previous three months trade. Its total trading volume is 1.31m shares for the day, in comparison to its average trading volume of 1.53m shares.
Halozyme Therapeutics, Inc. is a biopharmaceutical company. The Company’s research focuses primarily on human enzymes that alter the extracellular matrix. The Company’s pipeline consists of multiple clinical stage products in diabetes, oncology and dermatology.
What HALO Charts Are Signaling for Traders? Find Out Here
GTx, Inc.(NASDAQ:GTXI) stock is at $1.50, unchanged from its previous close of $1.50. Its today’s volume is 1.29 shares, in comparison to its average trading volume of 1.79m shares. The stock opened the session at $1.57 and touched its highest price point at $1.59. GTx, Inc.’s lowest price point for the session stood at $1.47 and its 52 week price range stood at $1.31 - $7.24. The company has a total of 63.19 million outstanding shares and its total market capitalization is $94.78 million. Its beta value stands at1.20 times and earnings per share were $-0.68.
GTx, Inc. is a biopharmaceutical company. The Company is developing selective androgen receptor modulators (SARMs) , a drugs with the potential to prevents and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia (age related muscle loss).
Is GTXI Buy After The Recent Price Movement? Find Out Here
Apollo Investment Corp.(NASDAQ:AINV) opened the session at $7.81 and remained in the $7.80 $7.98 price range during the session. The stock is 1.92% higher, at $7.95. Volume closed the day at 1.30m shares, its average volume being 1.50m shares. The company has a total of 224.74 million outstanding shares and its total market capitalization is $1.79 billion. Its beta value stands at 1.71 times. AINV was a looser in the 5 days activity and looses about -0.25%. The one month performance of the stock was negative and it plunged almost -2.93%.
Apollo Investment Corporation (Apollo Investment) is a closed-end, non-diversified management investment company that has elected to be treated as a business development company. Its investment objective is to generate current income and capital appreciation.
Should AINV a Buy or Sell Now? Find Out Here
PMC-Sierra Inc(NASDAQ:PMCS) traded in the range of $6.24and $6.40 in its previous trading session. The stock recorded the volume of 1.27m shares, in comparison to its average daily trading volume of 2.26m shares. Company’s year to date performance remained optimistic with the rise of 24.22%. If we look at the last 6 months of trade, that is in the bearish zone with a fall of -0.93%. The stock opened at $6.26 and its closing price for the day was $6.36, up 2.09% from its previous close of $6.23 .
PMC-Sierra, Inc., is a semiconductor innovator transforming networks that connect, move and store digital content. The Company designs, develops, markets and supports semiconductor solutions by integrating its mixed-signal, software and systems through a network of offices in North America, Europe and Asia.
What PMCS Charts Are Signaling for Traders? Find Out Here
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you&aposre new to penny stocks or a seasoned veteran, you&aposll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway&aposs service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
For more information on this press release visit: http://www.sbwire.com/press-releases/worth-watching-stocks-halozyme-therapeutics-incnasdaqhalo-gtx-incnasdaqgtxi-apollo-investment-corpnasdaqainv-pmc-sierra-incnasdaqpmcs-323224.htmMedia Relations Contact
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here